Bin Huang

Bin Huang is a declared insider of Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.), with filings sourced from SEDI. Between 1 December 2014 and 21 June 2018, the trades on record add up to 18 filings.

The open-market side counts 2 purchases alongside 9 sales. The totals do not cover 11 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 option exercises. Since January 2018: 2 purchases and 3 sales on the market.

Most recently, on 22 June 2018, the filings show an open-market sale in Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.). The most recent open-market purchase was published on 22 June 2018, 3,047 days ago. The median gap between a trade and its publication by SEDI is 3 days. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.